FRA
Front Row Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66K | Hold |
20
| – | – | ﹤0.01% | 476 |
|
|
2025
Q1 | $1.62K | Hold |
20
| – | – | ﹤0.01% | 453 |
|
|
2024
Q4 | $1.8K | Hold |
20
| – | – | ﹤0.01% | 448 |
|
|
2024
Q3 | $1.98K | Hold |
20
| – | – | ﹤0.01% | 446 |
|
|
2024
Q2 | $1.85K | Hold |
20
| – | – | ﹤0.01% | 856 |
|
|
2024
Q1 | $1.9K | Hold |
20
| – | – | ﹤0.01% | 850 |
|
|
2023
Q4 | $1.79K | Hold |
20
| – | – | ﹤0.01% | 418 |
|
|
2023
Q3 | $1.46K | Hold |
20
| – | – | ﹤0.01% | 844 |
|
|
2023
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 830 |
|
|
2023
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 845 |
|
|
2022
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 810 |
|
|
2022
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 843 |
|
|
2022
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 910 |
|
|
2022
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 882 |
|
|
2021
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 896 |
|
|
2021
Q3 | $3K | Hold |
20
| – | – | ﹤0.01% | 835 |
|
|
2021
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 893 |
|
|
2021
Q1 | $3K | Hold |
20
| – | – | ﹤0.01% | 835 |
|
|
2020
Q4 | $3K | Hold |
20
| – | – | ﹤0.01% | 798 |
|
|
2020
Q3 | $3K | Hold |
20
| – | – | ﹤0.01% | 795 |
|
|
2020
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 885 |
|
|
2020
Q1 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 859 |
|